KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Prepaid Assets (2016 - 2025)

Bristol Myers Squibb (BMY) has disclosed Prepaid Assets for 17 consecutive years, with $5.5 billion as the latest value for Q2 2025.

  • On a quarterly basis, Prepaid Assets changed N/A to $5.5 billion in Q2 2025 year-over-year; TTM through Jun 2025 was $5.5 billion, a N/A change, with the full-year FY2024 number at $5.6 billion, down 4.91% from a year prior.
  • Prepaid Assets was $5.5 billion for Q2 2025 at Bristol Myers Squibb, down from $5.6 billion in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $7.2 billion in Q3 2023 to a low of $4.8 billion in Q4 2021.
  • A 5-year average of $5.7 billion and a median of $5.6 billion in 2024 define the central range for Prepaid Assets.
  • Peak YoY movement for Prepaid Assets: grew 19.93% in 2022, then fell 21.98% in 2024.
  • Bristol Myers Squibb's Prepaid Assets stood at $4.8 billion in 2021, then rose by 19.93% to $5.8 billion in 2022, then rose by 1.93% to $5.9 billion in 2023, then decreased by 4.91% to $5.6 billion in 2024, then decreased by 2.69% to $5.5 billion in 2025.
  • Per Business Quant, the three most recent readings for BMY's Prepaid Assets are $5.5 billion (Q2 2025), $5.6 billion (Q4 2024), and $5.6 billion (Q3 2024).